These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22199323)

  • 1. Circulating CD95-ligand as a potential prognostic marker for recurrence in patients with synchronous colorectal liver metastases.
    Hoogwater FJ; Snoeren N; Nijkamp MW; Gunning AC; VAN Houdt WJ; DE Bruijn MT; Voest EE; VAN Hillegersberg R; Kranenburg O; Rinkes IH
    Anticancer Res; 2011 Dec; 31(12):4507-12. PubMed ID: 22199323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
    Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
    Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
    Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
    Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T; Toi M; Tominaga T
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].
    Scheele J; Altendorf-Hofmann A; Stangl R; Schmidt K
    Swiss Surg; 1996; Suppl 4():4-17. PubMed ID: 8963836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
    Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
    Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.
    Zabaleta J; Aguinagalde B; Fuentes MG; Bazterargui N; Izquierdo JM; Hernández CJ; Enriquez-Navascués JM; Emparanza JI
    Eur J Surg Oncol; 2011 Sep; 37(9):786-90. PubMed ID: 21723689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients.
    Marín LA; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Ramírez P; García-Alonso AM; Parrilla P; Alvarez-López MR; Muro M
    Transpl Immunol; 2012 Mar; 26(2-3):94-100. PubMed ID: 22182632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
    Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
    Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer.
    Nadal C; Maurel J; Gallego R; Castells A; Longarón R; Marmol M; Sanz S; Molina R; Martin-Richard M; Gascón P
    Clin Cancer Res; 2005 Jul; 11(13):4770-4. PubMed ID: 16000573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
    Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome.
    van der Pool AE; Lalmahomed ZS; Ozbay Y; de Wilt JH; Eggermont AM; Jzermans JN; Verhoef C
    Colorectal Dis; 2010 Oct; 12(10 Online):e229-35. PubMed ID: 19912286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer.
    Tomizawa N; Ohwada S; Ogawa T; Tanahashi Y; Koyama T; Hamada K; Kawate S; Sunose Y
    Hepatogastroenterology; 2006; 53(67):89-93. PubMed ID: 16506383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.